List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17131 studies with search of: blood disorders
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Evaluation of Patients With Blood Disorders
Condition: Hematologic Disease
Intervention:
2 Recruiting Screening for Subjects to Participate in Studies of Blood Disorders
Conditions: Bone Marrow Transplant;   Sickle Cell Disease
Intervention:
3 Not yet recruiting Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
Conditions: Hematological Malignancy;   Bone Marrow Failure Syndrome
Interventions: Drug: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders;   Radiation: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders;   Procedure: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders
4 Recruiting Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies
Conditions: Hematological Disease;   Lymphoid Malignancies
Intervention: Drug: CHR-2845
5 Recruiting Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Conditions: Neoplasms;   Hematologic Neoplasms
Intervention:
6 Recruiting Evaluation, Treatment, and Training for Patients With Blood Disorders
Conditions: Hematologic Disease;   Hematologic Neoplasm;   Pancytopenia
Intervention:
7 Active, not recruiting Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant
Conditions: Myelodysplastic and Myeloproliferative Disorders;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Multiple Myeloma;   Plasma Cell Dyscrasia;   Lymphoproliferative Disorders;   Hematologic Diseases
Interventions: Drug: Campath;   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Hematopoietic stem cell infusion;   Drug: FK-506
8 Recruiting Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
Conditions: Hematologic Diseases;   Healthy Volunteers
Intervention: Genetic: Isolation of genomic DNA
9 Completed Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
Conditions: Hematological Neoplasms;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Bulsulfex, Fludarabine, ALemtuzumab
10 Recruiting Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: ciprofloxacin;   Drug: cefepime
11 Recruiting Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
Conditions: Hematological Diseases;   Hematological Malignancies;   Blood Diseases;   Malignant Lymphoma;   Leukemia;   Multiple Myeloma
Interventions: Drug: Bismuth tablets;   Drug: Placebo tablets
12 Completed Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
Conditions: Anemia, Aplastic;   Hematologic Diseases;   Pancytopenia;   Blood Disease
Interventions: Drug: antilymphocyte serum;   Drug: nandrolone
13 Recruiting Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia;   Lymphoma
Intervention: Other: biologic sample preservation procedure
14 Active, not recruiting Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
Conditions: AML;   ALL;   CML Chronic Phase, Accelerated Phase, or Blast Crisis;   CLL;   MDS;   RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA;   Aplastic Anemia;   Multiple Myeloma;   MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)
Interventions: Drug: Cyclophosphamide;   Drug: fludarabine;   Drug: cyclosporine;   Drug: methotrexate;   Biological: G-CSF
15 Recruiting Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Conditions: Leukemia;   Non-Hodgkins Lymphoma;   Hodgkins Lymphoma;   MDS;   Multiple Myeloma
Interventions: Drug: EPOCH-F/R;   Drug: FLAG;   Drug: Transplant Preparative Regimen (Flu/Cy/Mes);   Drug: GVHD Prophylaxis (tacrolimus and sirolimus);   Procedure: Double Cord Blood Transplantation
16 Recruiting Stem Cell Transplant for Hematologic Diseases and Renal Cell Cancer
Condition: Hematologic Malignancies
Interventions: Biological: Campath 1H;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Radiation: TBI
17 Recruiting Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Procedure: peripheral blood stem cell transplantation
18 Recruiting Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
19 Recruiting Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Other: laboratory biomarker analysis;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
20 Completed Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Conditions: Anemia, Hemolytic, Autoimmune;   Felty Syndrome;   Purpura, Thrombocytopenic;   Autoimmune Diseases
Interventions: Drug: cyclophosphamide;   Drug: filgrastim

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services